Vanguard Group’s Xilio Therapeutics XLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $783K | Buy |
|
|||||
|
2025
Q1 | $822K | Buy |
|
|||||
|
2024
Q4 | $862K | Hold |
|
|||||
|
2024
Q3 | $711K | Hold |
|
|||||
|
2024
Q2 | $855K | Hold |
|
|||||
|
2024
Q1 | $975K | Hold |
|
|||||
|
2023
Q4 | $496K | Buy |
|
|||||
|
2023
Q3 | $1.88M | Hold |
|
|||||
|
2023
Q2 | $2.33M | Hold |
|
|||||
|
2023
Q1 | $2.82M | Hold |
|
|||||
|
2022
Q4 | $2.4M | Sell |
|
|||||
|
2022
Q3 | $2.6M | Buy |
|
|||||
|
2022
Q2 | $1.22M | Buy |
|
|||||
|
2022
Q1 | $2.94M | Sell |
|
|||||
|
2021
Q4 | $6.79M | Buy |
|